Literature DB >> 16685827

A segmentation and reconstruction technique for 3D vascular structures.

Vincent Luboz1, Xunlei Wu, Karl Krissian, Carl-Fredrik Westin, Ron Kikinis, Stéphane Cotin, Steve Dawson.   

Abstract

In the context of stroke therapy simulation, a method for the segmentation and reconstruction of human vasculature is presented and evaluated. Based on CTA scans, semi-automatic tools have been developed to reduce dataset noise, to segment using active contours, to extract the skeleton, to estimate the vessel radii and to reconstruct the associated surface. The robustness and accuracy of our technique are evaluated on a vascular phantom scanned in different orientations. The reconstructed surface is compared to a surface generated by marching cubes followed by decimation and smoothing. Experiments show that the proposed technique reaches a good balance in terms of smoothness, number of triangles, and distance error. The reconstructed surface is suitable for real-time simulation, interactive navigation and visualization.

Entities:  

Mesh:

Year:  2005        PMID: 16685827     DOI: 10.1007/11566465_6

Source DB:  PubMed          Journal:  Med Image Comput Comput Assist Interv


  3 in total

1.  Hemodynamic Differences in Intracranial Aneurysms before and after Rupture.

Authors:  B M W Cornelissen; J J Schneiders; W V Potters; R van den Berg; B K Velthuis; G J E Rinkel; C H Slump; E VanBavel; C B L M Majoie; H A Marquering
Journal:  AJNR Am J Neuroradiol       Date:  2015-06-18       Impact factor: 3.825

2.  Scale-adaptive surface modeling of vascular structures.

Authors:  Jianhuang Wu; Mingqiang Wei; Yonghong Li; Xin Ma; Fucang Jia; Qingmao Hu
Journal:  Biomed Eng Online       Date:  2010-11-19       Impact factor: 2.819

3.  A Combined Morphometric and Statistical Approach to Assess Nonmonotonicity in the Developing Mammary Gland of Rats in the CLARITY-BPA Study.

Authors:  Maël Montévil; Nicole Acevedo; Cheryl M Schaeberle; Manushree Bharadwaj; Suzanne E Fenton; Ana M Soto
Journal:  Environ Health Perspect       Date:  2020-05-20       Impact factor: 9.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.